Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Microscience develops oral anthrax vaccine

April 24, 2003

Certican demonstrates superiority to azathioprine in lung transplant patients

April 17, 2003

New Rapamune indication approved

April 15, 2003

Grant supports development of CEL-1000 for viral encephalitis

April 9, 2003

APT-070 enters phase IIa trials

April 8, 2003

Epimmune discovers candidates for HPV vaccine under Genencor collaboration

April 4, 2003

Selective inhibitor of Itk designed at BMS as lead compound for T-cell-mediated disorders

April 1, 2003

Varicella-zoster virus vaccine mutant impaired for latent infection offered by NIH

March 28, 2003

West and Chiron collaborate on nasal diphtheria and tetanus vaccine

March 27, 2003

Human Genome Sciences develops ABthrax

March 20, 2003

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Bio Korea 2026 kicks off with spotlight on oligonucleotides
BioWorld
Three decades of trial-and-error, and the resulting safety data, in the oligonucleotide-based therapeutic space have paved way for the present-day innovations and...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...